dmat

Showing 1 - 1 of 1

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Dysferlinopathy, Miyoshi Myopathy, LGMDR2 Trial in Moscow

Enrolling by invitation
  • Dysferlinopathy
  • +3 more
    • Moscow, Russian Federation
      Human Stem Cells Institute
    Jul 25, 2022